Expression of p63 and p16 in primary and recurrent pterygia

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 244, Issue 10, 2006, Pages 1310-1314

  Ramalho, Fernando S ^a   Maestri, Claudia ^a   Ramalho, Leandra N Z ^a   Ribeiro Silva, Alfredo ^a   Romão, Erasmo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

p16; p63; Primary; Pterygium; Recurrent

Indexed keywords

PROTEIN P16; PROTEIN P63;

ADULT; ARTICLE; CELL DIFFERENTIATION; CONJUNCTIVA; CONTROLLED STUDY; CYTOPLASM; EPITHELIUM; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PTERYGIUM; RECURRENT DISEASE;

CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PTERYGIUM; RECURRENCE;

EID: 33749068041     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-006-0287-5     Document Type: Article

References (27)

1. Au NH, Gown AM, Cheang M, Huntsman D, Yorida E, Elliott WM, Flint J, English J, Gilks CB, Grimes HL (2004) p63 expression in lung carcinoma: a tissue microarray study of 408 cases. Appl Immunohistochem Mol Morphol 12:240-247
2. Austin P, Jakobiec FA, Iwamoto T (1983) Elastodysplasia and elastodystrophy as the pathologic bases of ocular pterygia and pinguecula. Ophthalmology 90:96-109
3. Auw-Haedrich C, Sundmacher R, Freudenberg N, Spelsberg H, Feltgen N, Maier P, Reinhard T (2005) Expression of p63 in conjunctival intraepithelial neoplasia and squamous cell carcinoma. Graefes Arch Clin Exp Ophthalmol 15:1-8
4. Clear AS, Chirambo MC, Hutt MSR (1979) Solar keratosis, pterygium, and squamous cell carcionoma of the conjunctiva in Malawi. Br J Ophthalmol 63:102-109
5. Coroneo MT, Di Girolamo N, Wakefield D (1999) The pathogenesis of pterygia. Curr Opin Opthalmol 10:282-288
6. Coroneo MT (1993) Pterygium as an early indicator of ultraviolet insolation: A hypothesis. Br J Ophthalmol 77:734-739
7. Di Como CJ, Urist MJ, Babayan I, Drobnjak M, Hedvat CV, Teruya-Feldstein J, Pohar K, Hoos A, Cordon-Cardo C (2002) p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 8:494-501
8. Di Girolamo N, Coroneo MT, Wakefield D (2003) UVB-elicited induction of MMP-1 expression in human ocular surface epithelial cells is mediated through the ERK1/2 MAPK-dependent pathway. Invest Ophthalmol Vis Sci 11:4705-4714
9. Di Iorio E, Barbaro V, Ruzza A, Ponzin D, Pellegrini G, De Luca M (2005) Isoforms of DeltaNp63 and the migration of ocular limbal cells in human corneal regeneration. Proc Natl Acad Sci USA 102:9523-9528
10. Dushku N, Reid TW (1994) Immunohistochemical evidence that human pterygia originate from the invasion of vimentin-expressing altered limbal epithelial basal cells. Curr Eye Res 13:473-481
11. Gologan O, Barnes EL, Hunt JL (2005) Potential diagnostic use of p16INK4A, a new marker that correlates with dysplasia in oral squamoproliferative lesions. Am J Surg Pathol 6:792-796
12. Hodges A, Smoller BR (2002) Immunohistochemical comparison of p16 expression in actinic keratoses and squamous cell carcinomas of the skin. Mod Pathol 11:1121-1125
13. Hussein MR (2005) Ultraviolet radiation and skin cancer: Molecular mechanisms. J Cutan Pathol 3:191-205
14. Irwin MS, Kaelin WG (2001) P53 family update: P73 and p63 develop their own identities. Cell Growth Differ 12:337-349
15. Kaufmann O, Fietze E, Mengs J, Dietel M (2001) Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol 116:823-830
16. Maisse C, Guerrieri P, Melino G (2003) P73 and p63 protein stability: the way to regulate function? Biochem Pharmacol 66:1555-1561
17. Massion PP, Taflan PM, Jamshedur Rahman SM, Yildiz P, Shyr Y, Edgerton ME, Westfall MD, Roberts JR, Pietenpol JA, Carbone DP, Gonzalez AL (2003) Significance of p63 amplification and overexpression in lung cancer development and prognosis. Cancer Res 21:7113-7121
18. Murphy N, Ring M, Heffron CC, King B, Killalea AG, Hughes C, Martin CM,McGuinness E, Sheils O, O'Leary JJ (2005) p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer. J Clin Pathol 5:525-534
19. Nilsson K, Svensson S, Landberg G (2004) Retinoblastoma protein function and p16INK4a expression in actinic keratosis, squamous cell carcinoma in situ and invasive squamous cell carcinoma of the skin and links between p16INK4a expression and infiltrative behavior. Mod Pathol 12:1464-1474
20. Pavey S, Conroy S, Russell T, Gabrielli B (1999) Ultraviolet radiation induces p16CDKN2A expression in human skin. Cancer Res 17:4185-4189
21. Reis-Filho JS, Simpson PT, Martins A, Preto A, Gartner F, Schmitt FC (2003) Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray. Virchows Arch 443:122-132
22. Reis-Filho JS, Torio B, Albergaria A, Schmitt FC (2002) P63 expression in normal skin and usual cutaneous carcinomas. J Cutan Pathol 9:517-523
23. Sakoonwatanyoo P, Tan DT, Smith DR (2004) Expression of p63 in pterygium and normal conjunctiva. Cornea 1:67-70
24. Trink B, Okami K, Wu L, Sriuranpong V, Jen J, Sidransky D (1998) A new human p53 homologue. Nat Med 4:747-748
25. Wang IJ, Hu FR, Chen PJ, Lin CT (2000) Mechanism of abnormal elastin gene expression in the pinguecular part of pterygia. Am J Pathol 4:1269-1276
26. Westfall MD, Pietenpol JA (2004) P63: Molecular complexity in development and cancer. Carcinogenesis 25:857-864
27. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D, McKeon F (1998) p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant negative activities. Mol Cell 2:305-316